| PCE | physical capacity evaluation; pseudocholinesterase |
|---|---|
| PCHE | pseudocholinesterase |
| PsChE | pseudocholinesterase |
| TC | typical carcinoid |
|---|---|
| ChE | Pseudocholinesterase |
| PCHE | Pseudocholinesterase |
| typical pseudocholinesterase | A cholinesterase formed in the liver and present in plasma; it catalyses the hydrolysis of succinylcholine, first into succinylmonocholine and choline, and then into choline and succinic acid. (05 Mar 2000) |
|---|
| typical achromatopsia | Achromatopsia with absent colour vision, nystagmus, reduced visual acuity, and light aversion. Synonym: rod monochromatism, typical achromatopsia. (05 Mar 2000) |
|---|---|
| atypical pseudocholinesterase | A genetic variant of cholinesterase that fails to catalyze the hydrolysis of succinylcholine. See: dibucaine number, fluoride number. (05 Mar 2000) |
| pseudocholinesterase | <enzyme> An enzyme involved in the breakdown of acetylcholine. Associated with acetylcholinesterase. Acetylcholinesterase is found in nerve tissue while pseudocholinesterase is found primarily in the liver. Measurement of pseudocholinesterase may be performed as a screening tool prior to the administration of electroconvulsive therapy. It is also useful in identifying organophosphate toxicity or congenital enzyme deficiencies. (06 Oct 1997) |
| pseudocholinesterase deficiency | An autosomal dominant disorder manifested by exaggerated responses to drugs ordinarily hydrolyzed by serum pseudocholinesterase (e.g., succinylcholine); believed to entail production of a variant enzyme that is less active than the normal enzyme in hydrolyzing appropriate substrates, but also abnormally resistant to the effects of anticholinesterases. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|